Opportunity ID: 347676

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AI-23-026
Funding Opportunity Title: Synthetic Nucleic Acid Platforms for HIV-1 (SNAPH): (R61/R33 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 20, 2023
Last Updated Date: Apr 20, 2023
Original Closing Date for Applications: Aug 02, 2023
Current Closing Date for Applications: Aug 02, 2023
Archive Date: Sep 07, 2023
Estimated Total Program Funding:
Award Ceiling: $500,000
Award Floor:

Eligibility

Eligible Applicants: Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
City or township governments
Native American tribal governments (Federally recognized)
Small businesses
Special district governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
Public and State controlled institutions of higher education
State governments
For profit organizations other than small businesses
Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to advance synthetic nucleic acid platforms for the rapid development and iterative testing of active and passive immunization strategies for HIV prevention, treatment, and cure. This funding opportunity will use a milestone-driven, biphasic award mechanism. Transition to the second phase will depend on the successful completion of milestones.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-23-026.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 347676 Full Announcement-RFA-AI-23-026 -> RFA-AI-23-026-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or after January 25, 2023 PKG00281281 Jul 02, 2023 Aug 02, 2023 View

Package 1

Mandatory forms

347676 RR_SF424_5_0-5.0.pdf

347676 PHS398_CoverPageSupplement_5_0-5.0.pdf

347676 RR_OtherProjectInfo_1_4-1.4.pdf

347676 PerformanceSite_4_0-4.0.pdf

347676 RR_KeyPersonExpanded_4_0-4.0.pdf

347676 RR_Budget_3_0-3.0.pdf

347676 PHS398_ResearchPlan_5_0-5.0.pdf

347676 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

347676 RR_SubawardBudget30_3_0-3.0.pdf

347676 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-10T16:44:05-05:00

Share This Post, Choose Your Platform!

About the Author: